Cost-effectiveness of first- v. second-generation antipsychotic drugs: Results from a randomised controlled trial in schizophrenia responding poorly to previous therapy

Linda M. Davies, Shôn Lewis, Peter B. Jones, Thomas R E Barnes, Fiona Gaughran, Karen Hayhurst, Alison Markwick, Helen Lloyd

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Cost-effectiveness of first- v. second-generation antipsychotic drugs: Results from a randomised controlled trial in schizophrenia responding poorly to previous therapy'. Together they form a unique fingerprint.

    Neuroscience

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Social Sciences

    Psychology